humanamnioticmesenchymal stemcell(Yuanpin Biotech)

人羊膜间充质干细胞（源品生物）

Report date: 2026/05/07 20:00:36

Base Information

Drug Namehumanamnioticmesenchymal stemcell(Yuanpin Biotech)
Drug Alias NamehAMSCs
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMenopausal symptomsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSource Cell Biotechnology Group Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSource Cell Biotechnology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsMenopausal symptomsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A